March 1, 2018 / 10:02 PM / 4 months ago

BRIEF-Synergy Pharmaceuticals Qtrly Loss Per Share ‍$0.16

* SYNERGY PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE

* QTRLY LOSS PER SHARE ‍$0.16

* Q4 EARNINGS PER SHARE VIEW $-0.19 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below